<DOC>
	<DOCNO>NCT02424383</DOCNO>
	<brief_summary>The objective patient registry assess clinical use Lutonix 035 DCB PTA Catheter heterogeneous patient population real world on-label clinical application .</brief_summary>
	<brief_title>Real-World Registry Assessing Clinical Use Lutonix 035 Drug Coated Balloon Catheter</brief_title>
	<detailed_description>The registry prospective , multicenter , single arm post-market real-world registry U.S. assess clinical use , safety outcome Lutonix 035 DCB Catheter Superficial Femoral Artery ( SFA ) Popliteal Arteries ( PA ) . Registry subject follow three year 's post-index procedure .</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<criteria>1 . The subject provide write informed consent use Informed Consent Form ( ICF ) review approve Institutional Review Board ( IRB ) site . 2 . The subject agree comply protocolmandated followup procedure visit . 3 . The subject â‰¥ 21 year old . 4 . The subject must lesion ( ) treat available Lutonix 035 DCB Catheter accord IFU . 1 . The subject unable unwilling provide inform consent . 2 . The subject unable unwilling comply patient registry protocol followup procedures visit . 3 . The subject another medical condition currently participate investigational drug investigational device study , , opinion Investigator , may cause him/her noncompliant protocol , confound data interpretation , associate life expectancy insufficient allow completion patient registry procedure followup .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>